Camilla Smith

发表

Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes.

K. Endresen, P. Aukrust, E. Stang, 2006, Blood.

Enhanced Expression of the Homeostatic Chemokines CCL19 and CCL21 in Clinical and Experimental Atherosclerosis: Possible Pathogenic Role in Plaque Destabilization

B. Fevang, K. Taskén, G. Hansson, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation.

G. Hansson, P. Olofsson, K. Endresen, 2006, Journal of the American College of Cardiology.

High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.

B. Fevang, S. Frøland, P. Aukrust, 2008, Cardiovascular research.

Soluble CXCL 16 Predicts Long-Term Mortality in Acute Coronary Syndromes

T. Omland, K. Caidahl, M. Hartford, 2009 .

Soluble CXCL16 Predicts Long-Term Mortality in Acute Coronary Syndromes

T. Omland, K. Caidahl, M. Hartford, 2009, Circulation.

Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome.

S. Tonstad, T. Ueland, P. Aukrust, 2010, European journal of endocrinology.

Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells – potential role of prostaglandin E2

K. Taskén, S. Frøland, P. Aukrust, 2004, Thrombosis and Haemostasis.

pulmonary hypertension Elevated levels of activin A in clinical and experimental

I. Sjaastad, S. Jonasson, G. Christensen, 2015 .

Elevated levels of activin A in clinical and experimental pulmonary hypertension.

I. Sjaastad, G. Christensen, T. Ueland, 2009, Journal of applied physiology.

Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis: Possible Role in Inflammation and Plaque Destabilization

S. Tonstad, A. Dahl, B. Bendz, 2007, Circulation.

Expression of Fractalkine (CX3CL1) and its Receptor, CX3CR1, Is Elevated in Coronary Artery Disease and Is Reduced During Statin Therapy

O. Quehenberger, P. Aukrust, J. Damås, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Increased Expression of Interleukin-1 in Coronary Artery Disease With Downregulatory Effects of HMG-CoA Reductase Inhibitors

S. Frøland, P. Aukrust, A. Semb, 2004, Circulation.

Treatment with the PPARg agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome

S. Tonstad, T. Ueland, P. Aukrust, 2010 .

Treatment with the PPAR g agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome

S. Tonstad, T. Ueland, P. Aukrust, 2010 .

Potential anti-inflammatory role of activin A in acute coronary syndromes.

K. Endresen, S. Frøland, T. Ueland, 2004, Journal of the American College of Cardiology.

Inflammatory Interaction Between LIGHT and Proteinase-Activated Receptor-2 in Endothelial Cells: Potential Role in Atherogenesis

G. Hansson, P. Olofsson, S. Frøland, 2008, Circulation research.

A validated UHPLC-MS/MS method for the measurement of riluzole in plasma and myocardial tissue samples.

S. Parker, J. Roberts, J. Lipman, 2017, Biomedical chromatography : BMC.

The complex role of T-cell-based immunity in atherosclerosis

T. Ueland, P. Aukrust, J. Damås, 2008, Current atherosclerosis reports.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Steve B Jones, K. Y. Wong, Chamil H. Hettiarachchi, 2021, Lancet.

Regulation of collagen synthesis and messenger RNA levels in normal and hypertrophic scar fibroblasts in vitro by interferon alfa‐2b

A. Ghahary, P. Scott, E. Tredget, 1993, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

A Potential Role of the CXC Chemokine GROα in Atherosclerosis and Plaque Destabilization: Downregulatory Effects of Statins

U. Hedin, G. Paulsson-Berne, G. Hansson, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Chemokines in cardiovascular risk prediction

T. Ueland, P. Aukrust, J. Damås, 2007, Thrombosis and Haemostasis.

Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome: Possible Role in Plaque Destabilization

G. Hansson, S. Frøland, T. Ueland, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation

T. Ueland, P. Aukrust, J. Damås, 2005, Expert opinion on pharmacotherapy.

Activin A Levels Are Associated With Abnormal Glucose Regulation in Patients With Myocardial Infarction

G. Andersen, T. Lekva, T. Ueland, 2011, Diabetes.

Enhanced Plasma Levels of LIGHT in Unstable Angina: Possible Pathogenic Role in Foam Cell Formation and Thrombosis

S. Frøland, P. Aukrust, J. Damås, 2005, Circulation.

Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes.

J. Herlitz, T. Omland, K. Caidahl, 2008, Journal of the American College of Cardiology.

Activin A and cardiovascular disease in type 2 diabetes mellitus

K. Birkeland, K. Endresen, S. Aakhus, 2012, Diabetes & vascular disease research.

Activin A and cardiovascular disease in type 2 diabetes mellitus

K. Birkeland, K. Endresen, S. Aakhus, 2012, Diabetes & vascular disease research.

Elevated levels of activin A in clinical and experimental pulmonary hypertension.

I. Sjaastad, G. Christensen, T. Ueland, 2009, Journal of applied physiology.

Increased Expression of Interleukin-1 in Coronary Artery Disease With Downregulatory Effects of HMG-CoA Reductase Inhibitors

S. Frøland, P. Aukrust, A. Semb, 2004, Circulation.